1. Home
  2. AVXL vs CIFR Comparison

AVXL vs CIFR Comparison

Compare AVXL & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • CIFR
  • Stock Information
  • Founded
  • AVXL 2004
  • CIFR 2021
  • Country
  • AVXL United States
  • CIFR United States
  • Employees
  • AVXL N/A
  • CIFR N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • CIFR Investment Bankers/Brokers/Service
  • Sector
  • AVXL Health Care
  • CIFR Finance
  • Exchange
  • AVXL Nasdaq
  • CIFR Nasdaq
  • Market Cap
  • AVXL 750.3M
  • CIFR 882.1M
  • IPO Year
  • AVXL N/A
  • CIFR N/A
  • Fundamental
  • Price
  • AVXL $9.31
  • CIFR $2.86
  • Analyst Decision
  • AVXL Strong Buy
  • CIFR Strong Buy
  • Analyst Count
  • AVXL 2
  • CIFR 10
  • Target Price
  • AVXL $44.00
  • CIFR $8.14
  • AVG Volume (30 Days)
  • AVXL 1.2M
  • CIFR 11.7M
  • Earning Date
  • AVXL 05-08-2025
  • CIFR 05-06-2025
  • Dividend Yield
  • AVXL N/A
  • CIFR N/A
  • EPS Growth
  • AVXL N/A
  • CIFR N/A
  • EPS
  • AVXL N/A
  • CIFR N/A
  • Revenue
  • AVXL N/A
  • CIFR $151,270,000.00
  • Revenue This Year
  • AVXL N/A
  • CIFR $111.15
  • Revenue Next Year
  • AVXL N/A
  • CIFR $80.27
  • P/E Ratio
  • AVXL N/A
  • CIFR N/A
  • Revenue Growth
  • AVXL N/A
  • CIFR 19.26
  • 52 Week Low
  • AVXL $3.25
  • CIFR $1.86
  • 52 Week High
  • AVXL $14.44
  • CIFR $7.99
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 55.97
  • CIFR 54.75
  • Support Level
  • AVXL $8.61
  • CIFR $2.20
  • Resistance Level
  • AVXL $9.17
  • CIFR $2.54
  • Average True Range (ATR)
  • AVXL 0.67
  • CIFR 0.28
  • MACD
  • AVXL 0.09
  • CIFR 0.13
  • Stochastic Oscillator
  • AVXL 80.67
  • CIFR 97.73

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About CIFR Cipher Mining Inc.

Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.

Share on Social Networks: